Skip to main content
Erschienen in: Journal of Inflammation 1/2015

Open Access 01.12.2015 | Poster presentation

Characterisation of the murine C-type lectin receptor CLECSF8 (MCL) reveals its expression on cells of the monocyte/neutrophil lineages and an inter-dependence with Mincle, but not Dectin-2

verfasst von: Bernhard Kerscher, Gillian J Wilson, Delyth M Reid, Sho Yamasaki, Janet A Willment, Gordon D Brown

Erschienen in: Journal of Inflammation | Sonderheft 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

C-type lectin-like receptors (CTLRs) play critical roles in immunity and homeostasis by recognising a great variety of microbial or endogenous ligands [1]. CLECSF8 is a member of the Dectin–2 family of CTLRs. Previous research indicates that CLECSF8 associates with the FcRγ adaptor, which is essential for surface expression and signalling through the SYK/CARD9 pathway. Recently, the mycobacterial cord factor (TDM, trehalose-6,6’-dimycolate) was identified as the ligand of CLECSF8, as shown previously for the closely related CTLR Mincle [2]. Indeed, we recently showed that CLECSF8 plays a critical role in human and murine anti-mycobacterial immunity [3]. In this study, we characterised CLECSF8 expression in the mouse under naïve and inflammatory conditions.

Materials and methods

We used newly generated anti-CLECSF8 monoclonal antibodies (mAB) to assess receptor expression in the mouse by flow cytometry. The co-dependence of CLECSF8 and Mincle or Dectin-2 was investigated in a transfected fibroblast cell line and primary CLECSF8-/- cells.

Results

We selected mAB clone 3A4, which was able to recognise CLECSF8 by ELISA and western blot to analyse CLECSF8 expression in the mouse by flow cytometry. While CLECSF8 transcript was widely expressed, CLECSF8 protein expression was predominantly found on monocytes/macrophages and neutrophils within e. g. the peritoneal cavity, blood and bone marrow. Notably, CLECSF8 was expressed only weakly in the lung, but strongly upregulated in a pulmonary Mycobacterium bovis BCG infection model. In vitro, CLECSF8 expression on thioglycollate elicited macrophages was strongly induced upon treatment with TLR agonists or microbial stimuli.
In agreement with previous reports, our data suggests that CLECSF8 associates with the signalling adaptor FcRγ. Interestingly, surface expression of CLECSF8 in a murine fibroblast cell line was greatly enhanced by co-transfection of Mincle, but not Dectin-2. Intriguingly, Mincle expression mirrored CLECSF8 expression in our in vitro stimulation experiments. Further analyses on wild-type and CLECSF8-/- primary macrophages in vitro, or cells harvested after intra-peritoneal and intra-tracheal instillation of BCG demonstrated a lack of Mincle-upregulation in the absence of CLECSF8.

Conclusion

CLECSF8 is a predominantly monocyte/macrophage and neutrophil expressed receptor, showing significant interdependence with Mincle, but not Dectin-2.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Kerscher B, Willment JA, Brown GD: The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol. 2013, 25: 271-277. 10.1093/intimm/dxt006.PubMedCentralCrossRefPubMed Kerscher B, Willment JA, Brown GD: The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol. 2013, 25: 271-277. 10.1093/intimm/dxt006.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Miyake Y, Toyonaga K, Mori D, Kakuta S, Hoshino Y, Oyamada A, Yamada H, Ono K, Suyama M, Iwakura Y, et al: C-type lectin MCL is an FcRgamma-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor. Immunity. 2013, 38: 1050-1062. 10.1016/j.immuni.2013.03.010.CrossRefPubMed Miyake Y, Toyonaga K, Mori D, Kakuta S, Hoshino Y, Oyamada A, Yamada H, Ono K, Suyama M, Iwakura Y, et al: C-type lectin MCL is an FcRgamma-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor. Immunity. 2013, 38: 1050-1062. 10.1016/j.immuni.2013.03.010.CrossRefPubMed
3.
Zurück zum Zitat Wilson GJ, Marakalala MJ, Hoving JC, van Laarhoven A, Drummond RA, Kerscher B, Keeton R, van de Vosse E, Ottenhoff TH, Plantinga TS, Alisjahbana B, Govender D, Besra GS, Netea MG, Reid DM, Willment JA, Jacobs M, Yamasaki S, van Crevel R, Brown GD: The C-Type Lectin Receptor CLECSF8/CLEC4D Is a key component of anti-mycobacterial immunity. Cell Host Microbe. 2015, 17 (2): 252-259. 10.1016/j.chom.2015.01.004.PubMedCentralCrossRefPubMed Wilson GJ, Marakalala MJ, Hoving JC, van Laarhoven A, Drummond RA, Kerscher B, Keeton R, van de Vosse E, Ottenhoff TH, Plantinga TS, Alisjahbana B, Govender D, Besra GS, Netea MG, Reid DM, Willment JA, Jacobs M, Yamasaki S, van Crevel R, Brown GD: The C-Type Lectin Receptor CLECSF8/CLEC4D Is a key component of anti-mycobacterial immunity. Cell Host Microbe. 2015, 17 (2): 252-259. 10.1016/j.chom.2015.01.004.PubMedCentralCrossRefPubMed
Metadaten
Titel
Characterisation of the murine C-type lectin receptor CLECSF8 (MCL) reveals its expression on cells of the monocyte/neutrophil lineages and an inter-dependence with Mincle, but not Dectin-2
verfasst von
Bernhard Kerscher
Gillian J Wilson
Delyth M Reid
Sho Yamasaki
Janet A Willment
Gordon D Brown
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Journal of Inflammation / Ausgabe Sonderheft 1/2015
Elektronische ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-12-S1-P4

Weitere Artikel der Sonderheft 1/2015

Journal of Inflammation 1/2015 Zur Ausgabe

Oral presentation

Introduction and welcome

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.